Reflecting On The Syneos Health Acquisition: The Due Diligence Imperative
Summary
Finally, the acquirer must examine the companys existing clinical trial infrastructure, including its data management systems, patient recruitment strategies, investigator networks, and relationships with CROs. In the context of a private equity acquisition, especially in a global transaction, adherence to the Foreign Corrupt Practices Act (FCPA) and its equivalent in Organisation for Economic Co-operation and Development (OECD) nations is of paramount importance. This analysis should involve a comprehensive review of the target companys historical compliance with the FCPA, including any past or ongoing investigations or violations, as well as a detailed examination of its anti-bribery and anti-corruption policies, procedures, and controls. Ultimately, a robust FCPA due diligence process will help the acquiring entity to understand, manage, and mitigate potential risks, thereby ensuring a successful acquisition and safeguarding the investments value. In a global transaction involving a private equity acquisition, corporate due diligence serves as an essential tool to understand the legal, financial, and operational aspects of the target company.